Exact Mass: 428.241
Exact Mass Matches: 428.241
Found 500 metabolites which its exact mass value is equals to given mass value 428.241
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Irbesartan
Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2774 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.
Austalide L
Austalide L is a mycotoxin produced by Aspergillus ustu
Bedoradrine
Falipamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Lotrafiban
Xanthine amine congener
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
JOKBBQPBIIZMJV-UHFFFAOYSA-N
Ingenol-3,4,5,20-diacetonide is a natural compound.
Andrastin D
A 3-oxo steroid that is andrastin C in which the acetoxy group at the 3beta position has undergone formal oxidative cleavage to afford the corresponding 3-oxo derivative. A farnesyltransferase inhibitor produced by Penicillium roqueforti, a filamentous fungus involved in the ripening of several kinds of blue cheeses. CONFIDENCE Penicillium bissettii
17,18-Dihydro,17-hydroxy-(2,4,6-Trihydroxyphenyl)-5,8,11,14,17-eicosapentaen-1-one,9CI|2-(17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl)-1,3,5-trihydroxybenzene|2-[17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl]-1,3,5-trihydroxybenzene
12alpha-(2-methylbutyryloxy)-strictic acid methyl ester|12alpha-<2-methylbutyryloxy>-strictic acid methyl ester
(5-angeloyloxytiglinoyloxy)-costunolide|<5-angeloyloxytiglinoyloxy>-costunolide
3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-
(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-butanoate, 20-acetate
1alpha-acetoxy-3beta,6,8alpha-trihydroxy-2alpha-methoxy-2beta,14beta-epoxy-[4.2.1.10,301.1,4]-tricyclomeliac-7-oate
13,14-dihydroxy-15,16 dimethoxy-(-)-6alpha-hydroxy-5alpha,8alpha,9alpha,10alpha-cleroda-3-en-18-oic acid
2alpha-(4-methylsenecioyloxy)-15,16-epoxylabda-7,13(16),14-trien-18-oic acid|2alpha-<4-methylsenecioyloxy>-15,16-epoxylabda-7,13(16),14-trien-18-oic acid
gutierrezianolic acid (angelate) methyl ester|gutierrezianolic acid methyl ester|methyl 6alpha-angeloyloxy-15,16-epoxy-labda-7,13(16),14-trien-17-oate
7alpha,21-dihydroxy-3-oxo-24,25,26,27-tetranorapotirucall-14,20(22)-dien-21,23-olide
3,4-dimethoxy-benzoic acid 11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester|Cineverin|Cineverin (13-Veratroyloxy-lupanin)
(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-acetate, 20-butanoate
1beta-[(E-p-methoxycinnamoyl)oxy]-6alpha-hydroxyisodrimeninol
5beta,11-dihydroxy-iphionan-4-one-11-O-(alpha-xylopyranoside-2-O-acetate)|5beta,11-dihydroxy-iphionan-4-one-11-O-
19-norpregna-1,3,5(10),20-tetraen-3-O-alpha-fucopyranoside
4,5-dioxo-seco-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|4,5-dioxo-seco-gamma-eudesmol-
CAY10594
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
irbesartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1074 CONFIDENCE standard compound; INTERNAL_ID 2094 CONFIDENCE standard compound; INTERNAL_ID 8187 Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
Irbesartan (Avapro)
Irbesartan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=138402-11-6 (retrieved 2024-07-09) (CAS RN: 138402-11-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
(2R,2R,4aS,6R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalen]-6-yl acetate
((S)-2-((E)-6-((R)-3,3-dimethyloxiran-2-yl)-4-methylhex-3-en-1-yl)-8-formyl-5-hydroxy-2-methyl-2H-chromen-7-yl)methyl acetate
Ala Glu Ile Pro
Ala Glu Leu Pro
Ala Glu Pro Ile
Ala Glu Pro Leu
Ala Ile Glu Pro
Ala Ile Pro Glu
Ala Lys Asn Pro
Ala Lys Pro Asn
Ala Leu Glu Pro
Ala Leu Pro Glu
Ala Asn Lys Pro
Ala Asn Pro Lys
Ala Pro Glu Ile
Ala Pro Glu Leu
Ala Pro Ile Glu
Ala Pro Lys Asn
Ala Pro Leu Glu
Ala Pro Asn Lys
Asp Pro Val Val
Asp Val Pro Val
Asp Val Val Pro
Glu Ala Ile Pro
Glu Ala Leu Pro
Glu Ala Pro Ile
Glu Ala Pro Leu
Glu Ile Ala Pro
Glu Ile Pro Ala
Glu Leu Ala Pro
Glu Leu Pro Ala
Glu Pro Ala Ile
Glu Pro Ala Leu
Glu Pro Ile Ala
Glu Pro Leu Ala
Gly Lys Pro Gln
Gly Lys Gln Pro
Gly Pro Lys Gln
Gly Pro Gln Lys
Gly Gln Lys Pro
Gly Gln Pro Lys
Ile Ala Glu Pro
Ile Ala Pro Glu
Ile Glu Ala Pro
Ile Glu Pro Ala
Ile Ile Pro Ser
Ile Ile Ser Pro
Ile Leu Pro Ser
Ile Leu Ser Pro
Ile Pro Ala Glu
Ile Pro Glu Ala
Ile Pro Ile Ser
Ile Pro Leu Ser
Ile Pro Ser Ile
Ile Pro Ser Leu
Ile Pro Thr Val
Ile Pro Val Thr
Ile Ser Ile Pro
Ile Ser Leu Pro
Ile Ser Pro Ile
Ile Ser Pro Leu
Ile Thr Pro Val
Ile Thr Val Pro
Ile Val Pro Thr
Ile Val Thr Pro
Lys Ala Asn Pro
Lys Ala Pro Asn
Lys Gly Pro Gln
Lys Gly Gln Pro
Lys Asn Ala Pro
Lys Asn Pro Ala
Lys Pro Ala Asn
Lys Pro Gly Gln
Lys Pro Asn Ala
Lys Pro Gln Gly
Lys Gln Gly Pro
Lys Gln Pro Gly
Leu Ala Glu Pro
Leu Ala Pro Glu
Leu Glu Ala Pro
Leu Glu Pro Ala
Leu Ile Pro Ser
Leu Ile Ser Pro
Leu Leu Pro Ser
Leu Leu Ser Pro
Leu Pro Ala Glu
Leu Pro Glu Ala
Leu Pro Ile Ser
Leu Pro Leu Ser
Leu Pro Ser Ile
Leu Pro Ser Leu
Leu Pro Thr Val
Leu Pro Val Thr
Leu Ser Ile Pro
Leu Ser Leu Pro
Leu Ser Pro Ile
Leu Ser Pro Leu
Leu Thr Pro Val
Leu Thr Val Pro
Leu Val Pro Thr
Leu Val Thr Pro
Asn Ala Lys Pro
Asn Ala Pro Lys
Asn Lys Ala Pro
Asn Lys Pro Ala
Asn Pro Ala Lys
Asn Pro Lys Ala
Pro Ala Glu Ile
Pro Ala Glu Leu
Pro Ala Ile Glu
Pro Ala Lys Asn
Pro Ala Leu Glu
Pro Ala Asn Lys
Pro Asp Val Val
Pro Glu Ala Ile
Pro Glu Ala Leu
Pro Glu Ile Ala
Pro Glu Leu Ala
Pro Gly Lys Gln
Pro Gly Gln Lys
Pro Ile Ala Glu
Pro Ile Glu Ala
Pro Ile Ile Ser
Pro Ile Leu Ser
Pro Ile Ser Ile
Pro Ile Ser Leu
Pro Ile Thr Val
Pro Ile Val Thr
Pro Lys Ala Asn
Pro Lys Gly Gln
Pro Lys Asn Ala
Pro Lys Gln Gly
Pro Leu Ala Glu
Pro Leu Glu Ala
Pro Leu Ile Ser
Pro Leu Leu Ser
Pro Leu Ser Ile
Pro Leu Ser Leu
Pro Leu Thr Val
Pro Leu Val Thr
Pro Asn Ala Lys
Pro Asn Lys Ala
Pro Gln Gly Lys
Pro Gln Lys Gly
Pro Ser Ile Ile
Pro Ser Ile Leu
Pro Ser Leu Ile
Pro Ser Leu Leu
Pro Thr Ile Val
Pro Thr Leu Val
Pro Thr Val Ile
Pro Thr Val Leu
Pro Val Asp Val
Pro Val Ile Thr
Pro Val Leu Thr
Pro Val Thr Ile
Pro Val Thr Leu
Pro Val Val Asp
Gln Gly Lys Pro
Gln Gly Pro Lys
Gln Lys Gly Pro
Gln Lys Pro Gly
Gln Pro Gly Lys
Gln Pro Lys Gly
Ser Ile Ile Pro
Ser Ile Leu Pro
Ser Ile Pro Ile
Ser Ile Pro Leu
Ser Leu Ile Pro
Ser Leu Leu Pro
Ser Leu Pro Ile
Ser Leu Pro Leu
Ser Pro Ile Ile
Ser Pro Ile Leu
Ser Pro Leu Ile
Ser Pro Leu Leu
Thr Ile Pro Val
Thr Ile Val Pro
Thr Leu Pro Val
Thr Leu Val Pro
Thr Pro Ile Val
Thr Pro Leu Val
Thr Pro Val Ile
Thr Pro Val Leu
Thr Val Ile Pro
Thr Val Leu Pro
Thr Val Pro Ile
Thr Val Pro Leu
Val Asp Pro Val
Val Asp Val Pro
Val Ile Pro Thr
Val Ile Thr Pro
Val Leu Pro Thr
Val Leu Thr Pro
Val Pro Asp Val
Val Pro Ile Thr
Val Pro Leu Thr
Val Pro Thr Ile
Val Pro Thr Leu
Val Pro Val Asp
Val Thr Ile Pro
Val Thr Leu Pro
Val Thr Pro Ile
Val Thr Pro Leu
Val Val Asp Pro
Val Val Pro Asp
ZK118182 isopropyl ester
Austalide L
2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
1H-Azepine,hexahydro-1-[[[1-[2-(4-methyl-1-piperidinyl)-2-oxoethyl]-1H-benzimidazol-2-yl]thio]acetyl]-(9CI)
Pregna-1,4-dien-21-al, 16,17-[butylidenebis(oxy)]-11-hydroxy-3,20-dioxo-, (11β,16α)
Dicirenone
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal
11beta-hydroxy-D-homopregna-1,4-diene-3,20-dione 17a-butyrate
Bedoradrine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
1H-Benzimidazole-1-acetamide,N-cyclopentyl-2-[[2-(2,6-dimethyl-1-piperidinyl)-2-oxoethyl]thio]-(9CI)
HEXOCYCLIUM METHYLSULFATE
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
(3R,4R,5S)-ethyl 4-acetamido-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
[4-[3-(decyloxy)-2-hydroxypropoxy]-2-hydroxyphenyl] phenyl ketone
Umeclidinium
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
2-Phenyl-1-[4-(2-piperidin-1-YL-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-OL
N~2~-[(Benzyloxy)carbonyl]-N-[(1S,2S)-2-hydroxy-1-(4-hydroxybenzyl)propyl]-L-leucinamide
N-[2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl]naphthalene-2-carboxamide
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
2-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]-oxomethyl]-1,5-dimethyl-4-pyrrolo[3,2-c]quinolinone
N-(3-fluoro-4-methylphenyl)-4-[3-(4-methyl-1-piperidinyl)propylamino]-3-nitrobenzamide
3-[[cyclopentyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-8-methyl-1H-quinolin-2-one
(1R,2S,3S,4S)-4-formyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexyl (2E)-3-(4-methoxyphenyl)acrylate
N-[(1R,3S,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
(1R)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
(1S)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
2,3-Dihydroxypropyl (2-hydroxy-3-tridecoxypropyl) hydrogen phosphate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] dodecanoate
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
3,4a,5-trimethyl-6-[(2-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
1-ethylidene-7-isopropyl-3-[(2-methylbut-2-enoyl)oxy]-4-methylidene-2-oxo-hexahydroinden-5-yl 3-methylpent-2-enoate
(2s,3r,4s,5r)-4,5-dihydroxy-2-({2-[(1r,4r)-4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
2-(3,4-dimethylpent-3-en-1-yl)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboximidic acid
methyl (1r,4s,4as,8ar)-1-[2-(furan-3-yl)ethyl]-5,5,8a-trimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylate
(1r,3r,4ar,5s,8ar)-5-[2-(furan-3-yl)ethyl]-1,4a,6-trimethyl-3-{[(2e)-3-methylpent-2-enoyl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carboxylic acid
19-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
methyl 1-[2-(furan-3-yl)ethyl]-5,5,8a-trimethyl-4-[(2-methylbut-2-enoyl)oxy]-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylate
3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
2-{[2-(3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
8-formyl-1-hydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2,3-dimethylbutanoate
(1r,3s,4r,6s,7s,8s,9s,10r,13s,14s,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
2-{1-methoxy-4,8,12,12-tetramethyl-3,13-dioxatetracyclo[6.6.2.0²,⁶.0¹¹,¹⁵]hexadeca-2(6),4-dien-7-yl}ethenyl 3-methylbut-2-enoate
20-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
5,9a-dihydroxy-5b,9,9,11a-tetramethyl-2-(penta-1,3-dien-1-yl)-5,5a,6,7,10,11-hexahydro-1,12-dioxatetraphene-4,8-dione
methyl 1-hydroxy-2,3b,6,6,9a,11,11a-heptamethyl-3,7-dioxo-4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-3a-carboxylate
2-(2-hydroxy-1-methoxy-5,6-dimethylhept-5-en-2-yl)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2,3-dihydro-1h-indole-5-carboximidic acid
(4s,4ar,5r,6s,8as)-3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl (2z)-2-methylbut-2-enoate
17-(furan-3-yl)-6-(methoxycarbonyl)-2,10,14-trimethylheptadeca-2,6,10,14-tetraenoic acid
2-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(2s,3r,4s,5r)-2-({2-[(3r,3ar,5r,7as)-3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate
4,5-dihydroxy-2-({2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
10-({4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic acid
20r,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003438","Ingredient_name": "20r,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7189","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20s,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003472","Ingredient_name": "20s,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C)OC=O","Ingredient_weight": "428.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7190","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101244896","DrugBank_id": "NA"}